German Centre for Cardiovascular Research Cardiomyopathy Register
Studying AA amyloidosis
Last synced from ClinicalTrials.gov
Key facts
- Sponsor
- Heidelberg University
- Principal Investigator
- Hugo A Katus, MDHeidelberg University
- Enrollment
- 2300 enrolled
- Eligibility
- 18-79 years · All sexes
- Timeline
- 2014 – 2017
Study locations (1)
- University of Heidelberg, Heidelberg, Germany
Collaborators
Kerckhoff Klinik · University Hospital Goettingen · University of Hamburg-Eppendorf · University of Kiel · University of Luebeck · Mainz University · University Medical Centre Mannheim · Ludwig-Maximilians - University of Munich · Medical University of Hannover · Department for Community Medicine, University Medicine Greifswald · Goethe University · Charite University, Berlin, Germany · University Hospital Greifswald · German Heart Institute · ISAR Klinikum Munich
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02187263 on ClinicalTrials.govOther trials for AA amyloidosis
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06974877Repeat PET/CT Imaging in People With CAPS and Anakinra-Induced Amyloidosis Using an Amyloid-Reactive Peptide to Measure Changes in Organ-Specific Amyloid LoadNational Institute of Allergy and Infectious Diseases (NIAID)
- RECRUITINGNCT06354322Unclassified GENotypes of Autoinflammatory Diseases and AA AmyloidosisAssistance Publique - Hôpitaux de Paris
- RECRUITINGNCT04265040DZHK TORCH-Plus is a Registry for Patients With Cardiomyopathies and Serves as Source for Cardiovascular Research StudiesUniversity Hospital Heidelberg
- ACTIVE NOT RECRUITINGNANCT03584022Clinical Trial to Assess the Safety of a Novel Scaffold BiomaterialMayo Clinic